Ferroptosis in colorectal cancer: a future target?
- PMID: 36703079
- PMCID: PMC10070248
- DOI: 10.1038/s41416-023-02149-6
Ferroptosis in colorectal cancer: a future target?
Abstract
Colorectal cancer (CRC) is the third leading cause of cancer deaths worldwide and is characterised by frequently mutated genes, such as APC, TP53, KRAS and BRAF. The current treatment options of chemotherapy, radiation therapy and surgery are met with challenges such as cancer recurrence, drug resistance, and overt toxicity. CRC therapies exert their efficacy against cancer cells by activating biological pathways that contribute to various forms of regulated cell death (RCD). In 2012, ferroptosis was discovered as an iron-dependent and lipid peroxide-driven form of RCD. Recent studies suggest that therapies which target ferroptosis are promising treatment strategies for CRC. However, a greater understanding of the mechanisms of ferroptosis initiation, propagation, and resistance in CRC is needed. This review provides an overview of recent research in ferroptosis and its potential role as a therapeutic target in CRC. We also propose future research directions that could help to enhance our understanding of ferroptosis in CRC.
© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches.Cancers (Basel). 2023 Oct 30;15(21):5209. doi: 10.3390/cancers15215209. Cancers (Basel). 2023. PMID: 37958383 Free PMC article. Review.
-
Ferroptosis: the balance between death and survival in colorectal cancer.Int J Biol Sci. 2024 Jul 2;20(10):3773-3783. doi: 10.7150/ijbs.96828. eCollection 2024. Int J Biol Sci. 2024. PMID: 39113707 Free PMC article. Review.
-
Insights on Ferroptosis and Colorectal Cancer: Progress and Updates.Molecules. 2022 Dec 28;28(1):243. doi: 10.3390/molecules28010243. Molecules. 2022. PMID: 36615434 Free PMC article. Review.
-
Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets.Biomed Pharmacother. 2022 Sep;153:113524. doi: 10.1016/j.biopha.2022.113524. Epub 2022 Aug 13. Biomed Pharmacother. 2022. PMID: 36076606 Review.
-
Review of ferroptosis in colorectal cancer: Friends or foes?World J Gastroenterol. 2023 Jan 21;29(3):469-486. doi: 10.3748/wjg.v29.i3.469. Epub 2022 Jan 21. World J Gastroenterol. 2023. PMID: 36688016 Free PMC article. Review.
Cited by
-
LINC01232 promotes ARNTL2 transcriptional activation and inhibits ferroptosis of CRC cells through p300/H3K27ac.Epigenomics. 2024;16(15-16):1097-1115. doi: 10.1080/17501911.2024.2387528. Epub 2024 Sep 13. Epigenomics. 2024. PMID: 39268727
-
Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer.Front Med. 2024 Aug 27. doi: 10.1007/s11684-024-1082-6. Online ahead of print. Front Med. 2024. PMID: 39190270
-
Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions.Discov Oncol. 2024 Jul 20;15(1):294. doi: 10.1007/s12672-024-01163-1. Discov Oncol. 2024. PMID: 39031216 Free PMC article. Review.
-
A novel antitumor mechanism of triptonide in colorectal cancer: inducing ferroptosis via the SLC7A11/GPX4 axis.Funct Integr Genomics. 2024 Jul 16;24(4):126. doi: 10.1007/s10142-024-01402-2. Funct Integr Genomics. 2024. PMID: 39012393
-
Role of targeting ferroptosis as a component of combination therapy in combating drug resistance in colorectal cancer.World J Clin Oncol. 2024 Mar 24;15(3):375-377. doi: 10.5306/wjco.v15.i3.375. World J Clin Oncol. 2024. PMID: 38576594 Free PMC article.
References
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA: Cancer J Clin. 2022;72:7–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous